DCUN1D2-AS

Across TCGA pan-cancer cohorts, DCUN1D2-AS RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of DCUN1D2-AS’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where DCUN1D2-AS RNA is more highly expressed in tumor relative to normal tissue. In most cancer types DCUN1D2-AS is over-expressed in tumor, although a few such as KICH and KIRP show the opposite, repressed pattern.

BLCA, HNSC, and COAD are the cancer types where DCUN1D2-AS tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in DCUN1D2-AS RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	All	All	+0.370	.024	7	view →
HNSC	All	II,III,IV	+0.369	.003	6	view →
COAD	All	II,III,IV	+0.416	<.001	4	view →
LIHC	All	All	+0.178	<.001	4	view →
STAD	All	II,III,IV	+0.369	.010	3	view →
KICH	All	All	−0.344	<.001	3	view →
KIRP	Male	All	−0.263	.019	2	view →
CHOL	All	All	+0.615	.033	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

DCUN1D2-AS–BLCA

Open the BLCA breakdown →